| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/12/2004 | US20040029178 For anti-obesity/appetite enhancing drugs; prolactin inhibitors |
| 02/12/2004 | US20040029174 End selection in directed evolution |
| 02/12/2004 | US20040029167 Inducible COMT_II promoter, chimeric gene containing same and plants transformed therewith |
| 02/12/2004 | US20040029164 Methods for isolating a recombinant or transgenic polypeptide from egg albumen and a composition containing a transgeenic non-avian polypeptide |
| 02/12/2004 | US20040029163 Novel tissue-specific secretory polypeptide and dna thereof |
| 02/12/2004 | US20040029158 HOP - a novel cardiac-restricted transcriptional factor potentially useful for cardiac regeneration and specification |
| 02/12/2004 | US20040029157 A DNA containing a nucleotide sequence encoding the amino acid sequence with partial substitution, deletion or addition and having cell cycle control activity; for controlling abnormal cell growth like cancer |
| 02/12/2004 | US20040029150 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/12/2004 | US20040029148 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 02/12/2004 | US20040029147 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 02/12/2004 | US20040029146 Diagnosis and treatment of infectious diseases such as chlamydia |
| 02/12/2004 | US20040029145 Novel HMGA alleles and use of the same as genetic markers for growth, fatness, meat quality, and feed efficiency traits |
| 02/12/2004 | US20040029144 Used in the diagnosis, treatment, and prevention of cell proliferative disorders, including cancer, and developmental, autoimmune/inflammatory and neurological disorders |
| 02/12/2004 | US20040029141 Use of the genes and proteins to identify therapeutic agents for controlling insulin resistance syndrome and other related disorders such as non- insulin dependent diabetes mellitus (NDDM), dyslipidemia, obesity and atherosclerosis |
| 02/12/2004 | US20040029140 Therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving these proteins |
| 02/12/2004 | US20040029136 Diagnosing, treating, or preventing disorders associated with aberrant expression of lipid metabolism molecules (LMM) |
| 02/12/2004 | US20040029129 Sequence determination of antibody nucleic acids; antiproliferative agents; drug design |
| 02/12/2004 | US20040029123 Diagnosis of diseases associated with the cell cycle |
| 02/12/2004 | US20040029118 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments |
| 02/12/2004 | US20040029116 Proteins and nucleic acids encoding same |
| 02/12/2004 | US20040029115 Labeling a terminal monomer and scanning to determine the position; can analyze hundreds of macromolecules simultaneously |
| 02/12/2004 | US20040029114 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 02/12/2004 | US20040029113 Cleaving single-stranded nucleic acid sequences by contacting with a oligonucleotide; restriction endonuclease recognition site; fab fragments |
| 02/12/2004 | US20040029107 DNA sequence coding for bacteriophage recombinase; ligand-binding domain of steroid receptors; vectors |
| 02/12/2004 | US20040028705 Mutants of clostridium difficile toxin B and methods of use |
| 02/12/2004 | US20040028703 Genetic engineered, low molecular weight drug; therapy, vaccine; extraction of Clostridium |
| 02/12/2004 | US20040028701 E2 subunit vaccine comprising recombinant pestivirus E2 protein |
| 02/12/2004 | US20040028700 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 02/12/2004 | US20040028695 Prevent anthrax infections; fusion protein; forming vaccine |
| 02/12/2004 | US20040028694 Novel nanoparticles and use thereof |
| 02/12/2004 | US20040028693 Fusion protein viricides |
| 02/12/2004 | US20040028690 Nontoxic mucosal adjuvant |
| 02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/12/2004 | US20040028682 Inhibiting transforming growth factor beta to prevent accumulation of extracellular matrix |
| 02/12/2004 | US20040028680 Complexing fibroblast growth factor ; controlling elimination from cell |
| 02/12/2004 | US20040028669 Human gene critical to fertility |
| 02/12/2004 | US20040028652 Composition and method for stimulating immune response to pathogen using complex adenoviral vector |
| 02/12/2004 | US20040028651 Composition and methods of using hiv vpr |
| 02/12/2004 | US20040027537 Continuous two-dimensional corneal topography target |
| 02/12/2004 | DE10235168A1 Verfahren zur Reinigung von Preproinsulin A process for the purification of preproinsulin |
| 02/12/2004 | DE10234901A1 New nucleic acids encoding Mrp4, useful in the diagnosis of prostatic, bladder and ovarian tumors, also in screening for specific binding agents, and potential therapeutic agents |
| 02/12/2004 | DE10234739A1 New interfering splice variant of human p53 protein, useful for identifying modulators of p53 function, and potential anticancer agents |
| 02/12/2004 | DE10230210A1 Zusammensetzung und Verfahren zur Stabilisierung von Biomolekülen The composition and method of stabilizing biomolecules |
| 02/12/2004 | DE10225180A1 Protein oder Peptid (MIMPD), hierfür codierende Nukleinsäure sowie Verwendungen dieser Stoffe Protein or peptide (MIMPD), this encoding nucleic acid and uses of these substances |
| 02/12/2004 | CA2497400A1 Diagnosis of kidney damage and protection against same |
| 02/12/2004 | CA2495478A1 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 02/12/2004 | CA2495123A1 Methods of identifying compounds that modulate protein activity |
| 02/12/2004 | CA2494775A1 Manzamine-producing actinomycetes |
| 02/12/2004 | CA2494607A1 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | CA2494577A1 Mk2 interacting proteins |
| 02/12/2004 | CA2494471A1 Protein containing a burp domain |
| 02/12/2004 | CA2494368A1 Seed-associated promoter sequences |
| 02/12/2004 | CA2494311A1 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/12/2004 | CA2494276A1 Methods and reagents relating to inflammation and apoptosis |
| 02/12/2004 | CA2494240A1 Maxs as modifiers of the axin pathway and methods of use |
| 02/12/2004 | CA2493817A1 Use of biomarkers for detecting ovarian cancer |
| 02/12/2004 | CA2493752A1 Papsss as modifiers of the axin pathway and methods of use |
| 02/12/2004 | CA2492966A1 Method for the expression of unknown environmental dna into adapted host cells |
| 02/12/2004 | CA2492750A1 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions |
| 02/12/2004 | CA2492544A1 Modification of seed oil by the expression of a putative cytidyltransferase in transgenic plants |
| 02/12/2004 | CA2492497A1 Compositions, methods, and kits relating to behab and primary cns tumors |
| 02/12/2004 | CA2487528A1 Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation |
| 02/11/2004 | EP1388544A1 Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof |
| 02/11/2004 | EP1388283A1 Nonhuman model animal of oligodendrocyte development disability |
| 02/11/2004 | EP1387888A2 Nucleic acid-associated proteins |
| 02/11/2004 | EP1387884A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 02/11/2004 | EP1387856A2 Modified leptin with reduced immunogenicity |
| 02/11/2004 | EP1387855A2 Codon-optimised nucleic acid coding for apoaequorin and uses thereof |
| 02/11/2004 | EP1387854A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 02/11/2004 | EP1387852A2 Dna encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor |
| 02/11/2004 | EP1387697A2 Methods of treating antibody-mediated pathologies using agents which inhibit cd21 |
| 02/11/2004 | EP1387692A2 Molecular interactions in hematopoietic cells |
| 02/11/2004 | EP1387674A2 Hedgehog antagonists, methods and uses related thereto |
| 02/11/2004 | EP1176987B1 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics |
| 02/11/2004 | EP0970377B1 Diagnosis of epithelial cell abnormalities |
| 02/11/2004 | EP0961801B1 Monomers derived from hydroxy acids and polymers prepared therefrom |
| 02/11/2004 | EP0922225B1 Assay for quantifying arthritic conditions |
| 02/11/2004 | EP0888452B1 Human cyr61, an extracellular matrix signalling molecule |
| 02/11/2004 | EP0862615B1 Immunity against pasteurella haemolytica leukotoxin |
| 02/11/2004 | EP0858467B1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 02/11/2004 | EP0835125B1 Cd4-derived peptides that inhibit immune responses |
| 02/11/2004 | EP0804482B1 Cytokines that bind the cell surface receptor hek |
| 02/11/2004 | EP0655072B1 Immunological method for the detection of antibodies to equine herpesvirus type 1 and 4 glycoprotein G |
| 02/11/2004 | EP0506868B2 Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine |
| 02/11/2004 | CN1474871A Inhibitor proteins |
| 02/11/2004 | CN1474869A Novel compounds |
| 02/11/2004 | CN1474831A Membrane scaffold proteins |
| 02/11/2004 | CN1474830A 修饰的凝血因子viii Modified coagulation factor viii |
| 02/11/2004 | CN1474704A Multipurpose packages for sterilized products or products to be sterilised |
| 02/11/2004 | CN1473925A Heterotrophic medium composition for transgenenic chlorella |
| 02/11/2004 | CN1473852A Trivalent chromium composition and its use |
| 02/11/2004 | CN1473851A Jingzhao chilobrachys spider toxin |
| 02/11/2004 | CN1473850A New human protein with mouse NIH/3T3 cell transformation improving function and its code sequence |
| 02/11/2004 | CN1473849A Novel human protein with cancer inhibiting function and its code sequence |
| 02/11/2004 | CN1473848A Anti-tumor activity of Luffa acutangula 2 and its use |
| 02/11/2004 | CN1473847A Glycosidase activity of Luffa acutangula, and its use |
| 02/11/2004 | CN1473846A Method for producing rabbit alexin by high density heterotrophically cultivating transgenosis chlorella |
| 02/11/2004 | CN1473845A Polypeptide matter and its preparing method and use |
| 02/11/2004 | CN1473844A Polypeptide matter and its preparing method and use |
| 02/11/2004 | CN1138146C Method for detecting existence of anti-tissue transglutaminase antibody in body liquid externally |